Historical record - last NADAC effective date: 9/22/2021
Product Information
LEVALBUTEROL 1.25 MG/3 ML SOL is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.4006 per ML under NDC 47335075349. Its NADAC has been published 83 times since Feb 17, 2021.
FDA first approved this application on Nov 5, 2018.
Strength
1.25 mg/3mL
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
47335075349
Classification
Generic
Dosage Form
SOLUTION
Route
RESPIRATORY (INHALATION)
Effective Date
9/22/2021
Active Ingredients
LEVALBUTEROL HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207820FDA Approved
11/5/2018
On Market Since
12/1/2018
Pharmacological Classes
Price Statistics
The NADAC for LEVALBUTEROL 1.25 MG/3 ML SOL has been published 83 times since Feb 17, 2021, and over the history we have for it it has declined 7.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4006 per ML |
|---|---|
| All-time high | $0.4311 (Mar 10, 2021) |
| All-time low | $0.3402 (Mar 17, 2021) |
| Median price | $0.4006 |
| Average price | $0.3935 |
| Largest weekly change | -21.1% (Mar 17, 2021) |
| Weeks tracked | 83 |
| Tracking since | Feb 17, 2021 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
0.0%
All
-7.1%
Last surveyed Sep 14, 2022 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Levalbuterol Inhalation Solution market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Sun Pharmaceutical Industries Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levalbuterol Inhalation Solution market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
beta2-Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVALBUTEROL 1.25 MG/3 ML SOL?
The current National Average Drug Acquisition Cost (NADAC) for LEVALBUTEROL 1.25 MG/3 ML SOL, manufactured by Sun Pharmaceutical Industries Inc., is $0.4006 per ML (NDC 47335075349), effective Sep 14, 2022.
How has the price of LEVALBUTEROL 1.25 MG/3 ML SOL changed over time?
Over the history we have for it, the NADAC for LEVALBUTEROL 1.25 MG/3 ML SOL has declined 7.1%. It has been tracked across 83 weekly CMS publications since Feb 17, 2021.
What are the highest and lowest recorded NADAC prices for LEVALBUTEROL 1.25 MG/3 ML SOL?
Since Feb 17, 2021, the NADAC for LEVALBUTEROL 1.25 MG/3 ML SOL has ranged from a low of $0.3402 (Mar 17, 2021) to a high of $0.4311 (Mar 10, 2021), with a median of $0.4006 per ML.
Are there cheaper alternatives to LEVALBUTEROL 1.25 MG/3 ML SOL?
No other NADAC-published product currently shares the active ingredient and strength of LEVALBUTEROL 1.25 MG/3 ML SOL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LEVALBUTEROL 1.25 MG/3 ML SOL?
LEVALBUTEROL 1.25 MG/3 ML SOL (NDC 47335075349) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.